Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,253,826
in 9 filings, $2.1M under 10b5-1 plans

Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-13 Burnett Patrick Returned to the company · Stock Option (right to buy) −47,100 0
2024-02-13 Burnett Patrick Returned to the company · Stock Option (right to buy) −55,800 0
2024-02-13 Matsuda Masaru Grant or award +74,000 148,634
2024-02-13 Matsuda Masaru Grant or award +17,650 166,284
2024-02-13 Matsuda Masaru Grant or award +27,900 194,184
2024-02-13 Matsuda Masaru Returned to the company · Stock Option (right to buy) −185,000 0
2024-02-13 Matsuda Masaru Returned to the company · Stock Option (right to buy) −35,300 0
2024-02-13 Matsuda Masaru Returned to the company · Stock Option (right to buy) −55,800 0
2024-02-13 Watanabe Todd Franklin Grant or award +21,666 648,685
2024-02-13 Watanabe Todd Franklin Grant or award +33,066 681,751
2024-02-13 Watanabe Todd Franklin Grant or award +94,050 775,801
2024-02-13 Watanabe Todd Franklin Grant or award +116,100 891,901
2024-02-13 Watanabe Todd Franklin Returned to the company · Stock Option (right to buy) −65,000 0
2024-02-13 Watanabe Todd Franklin Returned to the company · Stock Option (right to buy) −99,200 0
2024-02-13 Watanabe Todd Franklin Returned to the company · Stock Option (right to buy) −188,100 0
2024-02-13 Watanabe Todd Franklin Returned to the company · Stock Option (right to buy) −232,200 0
2024-02-13 Smither John W Chief Financial Officer Grant or award +2,793 2,793
2024-02-13 Smither John W Chief Financial Officer Grant or award +8,572 11,365
2024-02-13 Smither John W Chief Financial Officer Returned to the company · Stock Option (right to buy) −8,379 0
2024-02-13 Smither John W Chief Financial Officer Returned to the company · Stock Option (right to buy) −25,718 0

Page 21 of 35 · 689 trades